FOLD Financial Facts
Total operating expenses: 46.72MNet loss: -46.65M
See Full Income Statement
Total current assets: 221.71M
Commitments and contingencies: 0
See Full Balance Sheet
Amicus Therapeutics, Inc. (FOLD) Earnings
|
Expand Research on FOLD
| Next EPS Date | 5/7/24 | EPS Growth Rate | +66.7% |
|---|---|---|---|
| Average EPS % Beat Rate | +16.1% | Revenue Growth Rate | +31.1% |
| Average % Move 1-Wk after EPS | -4.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/7/24 | Q124 | N/A | -$0.06 | N/A | N/A | $113.16M | N/A | N/A | N/A | ||
| 2/28/24 | Q423 | $0.01 | -$0.06 | +$0.07 | $115.08M | $114.35M | N/A |  | | Details | |
| 11/8/23 | Q323 | -$0.07 | -$0.08 | +$0.01 | $103.5M | $102.3M | N/A | | | Details | |
| 8/8/23 | Q223 | -$0.15 | -$0.11 | -$0.04 | $94.5M | $89.83M | N/A | | | Details | |
| 5/10/23 | Q123 | -$0.18 | -$0.14 | -$0.04 | $86.3M | $83.07M | N/A | | | Details | |
| 3/1/23 | Q422 | N/A | -$0.11 | N/A | N/A | $86.44M | N/A | N/A | N/A | ||
| 11/7/22 | Q322 | -$0.19 | -$0.19 | $0.00 | $79.55M | $84.33M | N/A | | | Details | |
| 8/4/22 | Q222 | -$0.21 | -$0.21 | $0.00 | $80.7M | $85.87M | N/A | | | Details |
